Li Y et al. investigates that IL-35 can inhibit the development of RA in CIA mice by a decrease in the expression level of RANKL and an increase in the expression level of OPG (osteoclastogenesis inhibitory factor) (Li et al., 2016a). The gene discussed is TNFRSF11B; the disease is rheumatoid arthritis.